c-LEcta is a fully integrated biotechnology company focused on enzyme engineering and bioprocess development for regulated markets such as the food and pharmaceutical industries.On February 15th, 2022, Kerry Group acquired a majority stake in c-LEcta for $155.34M.
Missing: c-LEcta's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: c-LEcta's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing c-LEcta
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
c-LEcta is included in 1 Expert Collection, including Biopharma Tech.
Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.
c-LEcta has filed 1 patent.
EC 2.4.1, Enzymes, EC 3.2.1, Protein domains, Molecular biology
EC 2.4.1, Enzymes, EC 3.2.1, Protein domains, Molecular biology
Latest c-LEcta News
Sep 23, 2022
c-LEcta Web Traffic
c-LEcta Frequently Asked Questions (FAQ)
When was c-LEcta founded?
c-LEcta was founded in 2004.
Where is c-LEcta's headquarters?
c-LEcta's headquarters is located at Perlickstr. 5, Leipzig.
What is c-LEcta's latest funding round?
c-LEcta's latest funding round is Corporate Majority.
How much did c-LEcta raise?
c-LEcta raised a total of $530K.
Who are the investors of c-LEcta?
Investors of c-LEcta include Kerry Group, Capricorn Partners, bm-t beteiligungsmanagement thuringen, Horizon 2020, High-Tech Grunderfonds and 3 more.
Who are c-LEcta's competitors?
Competitors of c-LEcta include Cathay Industrial Biotech, Fyodor Biotechnologies, Catalyst Biosciences, Iverson Genetic Diagnostics, Calibrant Biosystems and 13 more.
Compare c-LEcta to Competitors
Biolog specializes in microbial identification, phenotypic cell profiling, and metabolic fingerprinting for microbial and mammalian cells. The company’s products enable the identification of thousands of species of bacteria, yeast, and fungi, as well as the characterization of human cells and mitochondria. Biolog's products are available worldwide, either directly from the company or through its extensive network of international distributors. The company was founded in 1984 and is based in Hayward, California.
Adriacell s.r.l is a biotech company focused in oncology pharmaceuticals founded in Basovizza (Trieste) in March 2004 by Prof. Christian Kuehne, an Austrian citizen.nThe company is leveraging its efforts and scientific expertise to successfully solve important worldwide health problems; in particular, it has been striving to develop a new class of anti-tumour therapeutics and to create a series of powerful diagnostics for the early detection of cancer progression. The company is also developing new and highly powerful delivery solutions through small molecules as the basis for a new class of anti-infective drugs.nAdriaCell owns a patented system that can be used for the study of events subsequent to DNA double strand breaks, a very important issue for cancer research and diagnostics. Adriacell is currently evaluating a new class of therapeutics for cancer; its main lead compound is about to enter the pharmacokinetic and toxicology phases.nAdriacell Vision is to become a leader biotech drug development company concentrated in the development of solutions (treatment and diagnostics) for tumours characterized by low probability of survival for patients and of anti infective agents. Thanks to future developments in research and test activities Adriacell solutions will hopefully become useful in a wider range of pathologies.
Excelsyn integrate specialist management consulting, chemistry and engineering to offer a range of solutions that can enhance performance across the whole pharmaceuticals, biotech and chemicals value chain.
Laureate Pharma, Inc. is a full service contract manufacturing organization(CMO) providing development and cGMP manufacturing services in the company's FDA registered facilities in Princeton, New Jersey. The company is dedicated to supporting the development and commercialization of biopharmaceutical, drug and diagnostic products for pharmaceutical, diagnostic and biotech companies.The company aims to provide a range of product development and manufacturing services from cell line optimization and process design to development of full-scale cGMP protein production, purification and aseptic filling, in addition to corresponding testing, validation, analytical and regulatory support. The company's focus is on mammalian cell based monoclonal antibody and recombinant protein production for clinical and modest commercial supply.The company view the company's customers as partners and provide them with flexible solutions that reduce time to clinic and market. Focused on operational excellence, the company's highly experienced staff works with the company's customers to improve the quality of their products and processes.The company value the company's customers, stakeholders and associates. Therefore, the company measure the company's success by meeting the company's customers' needs, generating results in terms of quality, timeliness and on budget performance, as well as fostering an environment of trust, growth and diversity for the company's team.
The company provide business development services to clients in the pharmaceutical, biotechnology, consumer health, and drug delivery industries worldwide. The company's team members represent an array of nationalities and a mix of commercial, manufacturing, medical, and scientific expertise, gained from decades of experience with both global pharmaceutical and development-stage companies
VANADIS is focused on research and consultant activity, such as custom synthesis of organic and polymeric compounds. The preparation of lactic acid biodegradable polymers for biomedical applications, that relies on the company's long experience, is a key point within VANADIS activities.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.